SCA
LLY icon

Southpoint Capital Advisors’s Eli Lilly LLY Stock Holding History

Southpoint Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-60,000
Closed -$49.6M – 45
2025
Q1 		$49.6M Buy
+60,000
New +$49.9M 1.18% 30

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Southpoint Capital Advisors's LLY Position: Q2 2025 in Review

Southpoint Capital Advisors sold out of Eli Lilly (LLY) in Q2 2025, closing a stake of 60,000 shares — an estimated $49.6M sold.

Southpoint Capital Advisors first reported a position in LLY in Q1 2025 and held it in 1 quarter. The position peaked at $49.6M in Q1 2025. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.

  • Southpoint Capital Advisors reported no remaining Eli Lilly position as of Q2 2025 after selling out during the quarter.
  • Southpoint Capital Advisors sold 60,000 Eli Lilly shares in Q2 2025, an estimated $49.6M.
  • Southpoint Capital Advisors first reported a position in Eli Lilly in Q1 2025 and held it in 1 quarter.
  • Southpoint Capital Advisors's Eli Lilly position peaked at $49.6M in Q1 2025.
  • 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.

Based on Southpoint Capital Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.